NY-ESO-1 (157-165) C165V scrambled (MSILWQLVT) peptide – Immunology – Antigens/Epitotes/Pools/Librairies
NJ-peptide offers the scrambled MSILWQLVT peptide that can be used as a negative control of NY-ESO-1 (157-165) C165V variant epitope studies.
NJ-peptide also offers NY-ESO-1 (157-165) C165V (see section NY-ESO-1 (157-165) C165V).
HLA-A*02 allele is expressed in class I Human MHC Leukocyte Antigens (HLA),that are cell surface receptors,presenting peptides to the immune system. If a non-self-peptide is recognized by cytotoxic T-cells in the blood,cell death will be initiated via apoptosis.
Peptides presented by MHC class I molecule,are usually between 7 and 11 amino acids,originating from proteins expressed by the cell. SLLMWITQV peptide differes from the New York esophageal squamous cell carcinoma 1 (NY-ESO-1 : UniProt - P78358) native SLLMWITQC peptide,whose protein is part of a well-characterized group of cancer/testis antigens (CTAs).
Normally,NY-ESO-1 expression is restricted to germ cells and placental cells. However it is also expressed in 82% of neuroblastomas and 46% of melanomas,as well as in many other solid tumors and hematological malignancies.
Class I HLA molecules of the cancerous cells cited above present peptides from NY-ESO-1 protein,including SLLMWITQC,that binds the binding cleft of the HLA-A*0201 complex. NY-ESO-1 being the most immunogenic among the CTA family members,its peptides constitute attractive targets for specific immunotherapies and the stimulation of human NY-ESO-1 specific CD8+ T cells.
In order to better stimulate specific cytotoxic T-cells in PBMCs and analyze by ELISPOT peptide epitope,specificity,and cytokine production,like IFN-γ,SLLMWITQV variant peptide was used,as it is known to have a higher affinity for the binding cleft of the HLA-A*0201 complex than the native peptide. Moreover,SLLMWITQV has been used with adjuvant in protein nanoparticles in order to study cell-mediated immune responses and is also used in clinical trial to study the immunological effects of vaccines containing NY-ESO-1 (157-165) C165V.
IC-PEPTIDE also offers NY-ESO-1 (157-165) native peptide,as well as Biotin-NY-ESO-1 (157-165) C165V.
Technical specification
| Sequence | MSILWQLVT |
|---|
| MW | 1090 ,34 g/mol (C₅₁H₈₃N₁₁O₁₃S) |
|---|
| Purity | > 95% |
|---|
| Counter-ion | TFA Salts (see option TFA removal) |
|---|
| Delivery format | Freeze dried in propylene 2mL microtubes |
|---|
Price
| Product | Size | Price € | Price $ |
|---|
| NJ079-1MG | 1 mg | 88 € | 110 $ |